Assertio Holdings, Inc. Partners with Cove, a Leading Migraine Telemedicine Platform, To Launch Direct to Patient Digital Campaign to Increase Accessibility of CAMBIA® (diclofenac potassium) and SPRIX® (ketorolac tromethamine)
05. Mai 2021 09:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill. and NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT), and Cove, a leading migraine telemedicine platform, today...
Assertio Holdings, Inc. to Report First Quarter 2021 Financial Results After the Close of Markets on Thursday, May 6, 2021
22. April 2021 09:25 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release first quarter 2021 financial results...
Assertio Reports Fourth Quarter and Full Year 2020 Financial Results
11. März 2021 16:01 ET
|
Assertio Holdings, Inc.
Full Year Net Product Sales of $93.5 Million; Full Year Pro-Forma Revenue of $119.2 Million in Line with Guidance Post Year-end Raised $45.3 Million in Cash, Net of Expenses, from Closing of...
Assertio Holdings, Inc. to Present at Virtual Roth Conference on Monday, March 15, 2021
01. März 2021 16:01 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., March 01, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that Dan Peisert, President and Chief Executive Officer of...
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021
18. Februar 2021 16:01 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release fourth quarter and full year 2020...
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $34.3 Million
12. Februar 2021 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it closed its previously announced registered direct of...
Assertio Holdings, Inc. Announces Pricing of $34.3 Million Registered Direct Offering
10. Februar 2021 00:01 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with...
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $14 Million
09. Februar 2021 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it closed its previously announced registered direct of...
Assertio Holdings, Inc. Announces Pricing of $14 Million Registered Direct Offering
05. Februar 2021 00:05 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with...
Assertio Announces $5.0 Million Insurance Settlement and General Corporate Updates
03. Februar 2021 16:01 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that its subsidiary Assertio Therapeutics, Inc. (“Assertio...